Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

India's strategy for the prevention of head and neck cancers and lung cancer

Share :

Choosing Wisely: Value added cancer care for India

15 - 16 Oct 2019
Published: 20 Feb 2020
Views: 2580
Rating:
Save
Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India

Dr Abhishek Shankar presents a talk on 'India's strategy for the prevention of head and neck cancers and lung cancer' at the Choosing wisely: Value Added Cancer Care for India event in New Delhi.

Related Videos

Introducing oncology to undergraduate medical and allied health sciences...
Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India
Introducing oncology to undergraduate medical and allied health sciences students ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )
8 Dec 2023
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Carolyn Taylor - Executive Director, Global Focus on Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )
5 Sep 2023
Time toxicity: the burden on cancer patients
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
The time toxicity of cancer care
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
The time toxicity of cancer care ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Cancer Care in Older Adults and Special Population
Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023
Advocacy that impacts patients outcomes in Africa - challenges and opportunities
Franklin Mtei - Patient Advocate, Inspire2Live
Advocacy that impacts patients outcomes in Africa - challenges and opportunities ( Franklin Mtei - Patient Advocate, Inspire2Live )
22 Mar 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation